selegiline has been researched along with Adverse Drug Event in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bodkin, JA; Pae, CU; Patkar, AA; Portland, KB; Thase, ME | 1 |
| Azzaro, AJ; Blob, LF; Campbell, BJ; Gilmor, MG; Kemper, EM; Sharoky, M; VanDenberg, CM | 1 |
| Howland, RH | 1 |
| Preskorn, SH | 1 |
1 review(s) available for selegiline and Adverse Drug Event
| Article | Year |
|---|---|
Transdermal selegiline: a novel MAOI formulation for depression.
Topics: Administration, Cutaneous; Depressive Disorder; Diet; Drug-Related Side Effects and Adverse Reactions; Humans; Monoamine Oxidase Inhibitors; Selegiline | 2006 |
1 trial(s) available for selegiline and Adverse Drug Event
| Article | Year |
|---|---|
Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour.
Topics: Administration, Cutaneous; Adolescent; Adult; Blood Pressure; Cheese; Double-Blind Method; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Tyramine | 2007 |
6 other study(ies) available for selegiline and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures.
Topics: Administration, Cutaneous; Adult; Adverse Drug Reaction Reporting Systems; Aged; Depressive Disorder; Drug Eruptions; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Food-Drug Interactions; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Self-Injurious Behavior; Tyramine; United States | 2012 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; Dementia; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Hospitalization; Humans; Hypnotics and Sedatives; Lorazepam; Parkinson Disease; Psychomotor Agitation; Selegiline; Trihexyphenidyl | 2008 |
[A regional center for adverse effects in Umeå will stimulate increased reporting].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug-Related Side Effects and Adverse Reactions; Misoprostol; Registries; Selegiline; Sweden | 1992 |